Literature DB >> 16604350

Genome scans and gene expression microarrays converge to identify gene regulatory loci relevant in schizophrenia.

Marquis P Vawter1, Mary E Atz, Brandi L Rollins, Kathleen M Cooper-Casey, Ling Shao, William F Byerley.   

Abstract

Multiple linkage regions have been reported in schizophrenia, and some appear to harbor susceptibility genes that are differentially expressed in postmortem brain tissue derived from unrelated individuals. We combined traditional genome-wide linkage analysis in a multiplex family with lymphocytic genome-wide expression analysis. A genome scan suggested linkage to a chromosome 4q marker (D4S1530, LOD 2.17, theta = 0) using a dominant model. Haplotype analysis using flanking microsatellite markers delineated a 14 Mb region that cosegregated with all those affected. Subsequent genome-wide scan with SNP genotypes supported the evidence of linkage to 4q33-35.1 (LOD = 2.39) using a dominant model. Genome-wide microarray analysis of five affected and five unaffected family members identified two differentially expressed genes within the haplotype AGA and GALNT7 (aspartylglucosaminidase and UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase 7) with nominal significance; however, these genes did not remain significant following analysis of covariance. We carried out genome-wide linkage analyses between the quantitative expression phenotype and genetic markers. AGA expression levels showed suggestive linkage to multiple markers in the haplotype (maximum LOD = 2.37) but to no other genomic region. GALNT7 expression levels showed linkage to regulatory loci at 4q28.1 (maximum LOD = 3.15) and in the haplotype region at 4q33-35.1 (maximum LOD = 2.37). ADH1B (alcohol dehydrogenase IB) was linked to loci at 4q21-q23 (maximum LOD = 3.08) and haplotype region at 4q33-35.1 (maximum LOD = 2.27). Seven differentially expressed genes were validated with RT-PCR. Three genes in the 4q33-35.1 haplotype region were also differentially expressed in schizophrenia in postmortem dorsolateral prefrontal cortex: AGA, HMGB2, and SCRG1. These results indicate that combining differential gene expression with linkage analysis may help in identifying candidate genes and potential regulatory sites. Moreover, they also replicate recent findings of complex trans- and cis- regulation of genes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604350      PMCID: PMC2077091          DOI: 10.1007/s00439-006-0172-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  42 in total

1.  A family-based test for correlation between gene expression and trait values.

Authors:  Peter Kraft; Eric Schadt; Jason Aten; Steve Horvath
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

Review 2.  The genetics of variation in gene expression.

Authors:  Vivian G Cheung; Richard S Spielman
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 3.  A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets.

Authors:  E E Schadt; S A Monks; S H Friend
Journal:  Biochem Soc Trans       Date:  2003-04       Impact factor: 5.407

4.  Natural variation in human gene expression assessed in lymphoblastoid cells.

Authors:  Vivian G Cheung; Laura K Conlin; Teresa M Weber; Melissa Arcaro; Kuang-Yu Jen; Michael Morley; Richard S Spielman
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

Review 5.  Recent advances in the genetics of schizophrenia.

Authors:  Michael C O'Donovan; Nigel M Williams; Michael J Owen
Journal:  Hum Mol Genet       Date:  2003-09-02       Impact factor: 6.150

6.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

Authors:  Rafael A Irizarry; Bridget Hobbs; Francois Collin; Yasmin D Beazer-Barclay; Kristen J Antonellis; Uwe Scherf; Terence P Speed
Journal:  Biostatistics       Date:  2003-04       Impact factor: 5.899

7.  Genomewide linkage scan for schizophrenia susceptibility loci among Ashkenazi Jewish families shows evidence of linkage on chromosome 10q22.

Authors:  M Daniele Fallin; Virginia K Lasseter; Paula S Wolyniec; John A McGrath; Gerald Nestadt; David Valle; Kung-Yee Liang; Ann E Pulver
Journal:  Am J Hum Genet       Date:  2003-08-15       Impact factor: 11.025

8.  Genetics of gene expression surveyed in maize, mouse and man.

Authors:  Eric E Schadt; Stephanie A Monks; Thomas A Drake; Aldons J Lusis; Nam Che; Veronica Colinayo; Thomas G Ruff; Stephen B Milligan; John R Lamb; Guy Cavet; Peter S Linsley; Mao Mao; Roland B Stoughton; Stephen H Friend
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

9.  Neuregulin 1 and susceptibility to schizophrenia.

Authors:  Hreinn Stefansson; Engilbert Sigurdsson; Valgerdur Steinthorsdottir; Soley Bjornsdottir; Thordur Sigmundsson; Shyamali Ghosh; Jon Brynjolfsson; Steinunn Gunnarsdottir; Omar Ivarsson; Thomas T Chou; Omar Hjaltason; Birgitta Birgisdottir; Helgi Jonsson; Vala G Gudnadottir; Elsa Gudmundsdottir; Asgeir Bjornsson; Brynjolfur Ingvarsson; Andres Ingason; Sigmundur Sigfusson; Hronn Hardardottir; Richard P Harvey; Donna Lai; Mingdong Zhou; Daniela Brunner; Vincent Mutel; Acuna Gonzalo; Greg Lemke; Jesus Sainz; Gardar Johannesson; Thorkell Andresson; Daniel Gudbjartsson; Andrei Manolescu; Michael L Frigge; Mark E Gurney; Augustine Kong; Jeffrey R Gulcher; Hannes Petursson; Kari Stefansson
Journal:  Am J Hum Genet       Date:  2002-07-23       Impact factor: 11.025

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  15 in total

1.  ADH single nucleotide polymorphism associations with alcohol metabolism in vivo.

Authors:  Andrew J Birley; Michael R James; Peter A Dickson; Grant W Montgomery; Andrew C Heath; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2009-02-04       Impact factor: 6.150

2.  MicroRNA-382 expression is elevated in the olfactory neuroepithelium of schizophrenia patients.

Authors:  Eyal Mor; Shin-Ichi Kano; Carlo Colantuoni; Akira Sawa; Ruth Navon; Noam Shomron
Journal:  Neurobiol Dis       Date:  2013-03-29       Impact factor: 5.996

3.  Convergent genomic studies identify association of GRIK2 and NPAS2 with chronic fatigue syndrome.

Authors:  Alicia K Smith; Hong Fang; Toni Whistler; Elizabeth R Unger; Mangalathu S Rajeevan
Journal:  Neuropsychobiology       Date:  2011-09-09       Impact factor: 2.328

Review 4.  An integrative functional genomics approach for discovering biomarkers in schizophrenia.

Authors:  Marquis P Vawter; Firoza Mamdani; Fabio Macciardi
Journal:  Brief Funct Genomics       Date:  2011-12-08       Impact factor: 4.241

5.  Analysis of whole genome biomarker expression in blood and brain.

Authors:  Brandi Rollins; Maureen V Martin; Ling Morgan; Marquis P Vawter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-06-05       Impact factor: 3.568

6.  Allelic imbalance associated with the schizophrenia risk SNP rs1344706 indicates a cis-acting variant in ZNF804A.

Authors:  Ilaria Guella; Marquis P Vawter
Journal:  Schizophr Res       Date:  2014-01-23       Impact factor: 4.939

Review 7.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

8.  Common polygenic variation contributes to risk of migraine in the Norfolk Island population.

Authors:  A J Rodriguez-Acevedo; M A Ferreira; Miles C Benton; Melanie A Carless; Harald H Goring; Joanne E Curran; John Blangero; R A Lea; L R Griffiths
Journal:  Hum Genet       Date:  2015-07-29       Impact factor: 4.132

9.  Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.

Authors:  Christine L Miller; Peter Murakami; Ingo Ruczinski; Randal G Ross; Melissa Sinkus; Bernadette Sullivan; Sherry Leonard
Journal:  Schizophr Res       Date:  2009-06-06       Impact factor: 4.939

10.  Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.

Authors:  Maureen V Martin; Brandi Rollins; P Adolfo Sequeira; Andrea Mesén; William Byerley; Richard Stein; Emily A Moon; Huda Akil; Edward G Jones; Stanley J Watson; Jack Barchas; Lynn E DeLisi; Richard M Myers; Alan Schatzberg; William E Bunney; Marquis P Vawter
Journal:  BMC Med Genomics       Date:  2009-09-22       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.